Can assessment of small airway dysfunction support the diagnosis or management of asthma exacerbations in children? A systematic review [0.03%]
小气道功能障碍的评估能否支持儿童哮喘急性加重期的诊断或管理？系统评价
Abdulrahman Alshehri,Mohammed Ibrahim Alshahrani,Elizabeth Sapey et al.
Abdulrahman Alshehri et al.
Background: Asthma exacerbations are acute episodes associated with worsening symptoms and lung function decline. In children, diagnosis and monitoring rely largely on clinical judgment and measures of large airway functi...
The usefulness of full-thickness biopsy during semi-rigid pleuroscopy for differentiating between malignant pleural mesothelioma and non-specific pleurisy [0.03%]
半刚性胸腔镜检查时行全层活检鉴别恶性间皮瘤与非特异性胸膜炎的价值
Takahiro Ueda,Toshiyuki Nakai,Sayaka Tanaka et al.
Takahiro Ueda et al.
Background: Malignant pleural mesothelioma is a rare disease with a poor prognosis; distinguishing it from non-specific pleurisy is essential for determining an appropriate treatment strategy. We aimed to evaluate the dia...
Prognostic factors and a nomogram for survival in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease [0.03%]
抗MDA5抗体阳性皮肌炎相关间质性肺病的预后因素及生存预测列线图模型
Baolu Yang,Zhaohui Tong
Baolu Yang
Objectives: To characterize the clinical features and identify determinants of mortality in patients with dermatomyositis (DM)-associated interstitial lung disease (ILD) who are positive for anti-melanoma differentiation-...
A case of pulmonary nodular lesion caused by Tropheryma whipplei infection: a case report and literature review [0.03%]
Whipple氏体感染所致肺结节病1例报告及文献复习
Rong Bao,Liping Ma,Wenjing Wang
Rong Bao
Background: Tropheryma whipplei is a Gram-positive aerobic bacillus belonging to the phylum Actinobacteria. It is the causative agent of Whipple's disease, a multi-systemic illness that can lead to pneumonia when the lung...
Reduction of low attenuation areas of emphysema after lung volume reduction surgery compared to bronchoscopic lung volume reduction with valves [0.03%]
与带瓣膜支气管内肺减容相比外科肺减容术后减少肺气肿低衰减区的面积
Julia von Rotz,Jan Mengers,Thomas Gaisl et al.
Julia von Rotz et al.
Background: Lung volume reduction surgery (LVRS) enables a tailored resection of emphysematous lung areas, whereas bronchoscopic lung volume reduction (BLVR) with valves excludes a whole lobe. We hypothesize greater reduc...
Comparative Study
BMC pulmonary medicine. 2025 Dec 8;25(1):555. DOI:10.1186/s12890-025-04036-7 2025
The prevalence of Mycobacterium tuberculosis and rifampicin-resistance strains using GeneXpert-MTB/RIF assay in Ethiopia: a systematic review and meta-analysis [0.03%]
基于GeneXpert-MTB/RIF试验的耐利福平结核分枝杆菌流行病学的系统评价和meta分析：来自埃塞俄比亚的数据
Mengistu Abayneh,Ahmed Zeynudin,Yared Alemu et al.
Mengistu Abayneh et al.
Background: The spread of tuberculosis (TB), including strains resistant to at least rifampicin and/or isoniazid, remains a major public health problem in developing nations, yet few comprehensive and comparative data on ...
Gender-age-physiology stage and body mass index are useful predictors of nintedanib discontinuation and prognosis in patients with idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung diseases [0.03%]
特发性肺纤维化和进行性间质性肺疾病的性别、年龄、生理阶段和体质指数是尼达尼布停药和预后的有效预测指标
Kai Yazaki,Masashi Matsuyama,Hiroaki Satoh et al.
Kai Yazaki et al.
Introduction: Data on risk factors for discontinuation of nintedanib in patients with interstitial lung diseases (ILDs) are limited. The differences in tolerability between patients with idiopathic pulmonary fibrosis (IPF...
Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case series and literature review [0.03%]
慢性阻塞性肺疾病患者的过敏性支气管肺真菌病：病例系列和文献综述
Jiaqi Ren,Ying Luo,Lina Sun et al.
Jiaqi Ren et al.
Background: Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity disorder caused by Aspergillus sensitization, mostly associated with asthma, but occasionally seen in patients with chronic obstruct...
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) [0.03%]
用于特发性肺纤维化和进行性肺纤维化的尼拉米司他（BI 1015550）开放标签延长试验的设计（FIBRONEER™-ON）
Wim A Wuyts,Luca Richeldi,Shervin Assassi et al.
Wim A Wuyts et al.
Background: There is a need for more effective treatments for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Nerandomilast (BI 1015550), an oral preferential inhibitor of phosphodiesterase 4...
Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trial [0.03%]
有关慢性阻塞性肺病患者的长效毒蕈碱拮抗剂晚间给药的一项随机对照试验
Pradeesh Sivapalan,Valdemar Rømer,Alexander Jordan et al.
Pradeesh Sivapalan et al.
Background: Night-time parasympathetic activation, diminished effect of long-acting muscarinic antagonists (LAMA) closer to end of the dosing period, and frequent exacerbations in chronic obstructive pulmonary disease (CO...
Randomized Controlled Trial
BMC pulmonary medicine. 2025 Dec 3;25(1):552. DOI:10.1186/s12890-025-03952-y 2025